YKL075C Antibody

What is YKL075C and why would researchers need antibodies against it?

YKL075C (AAN1) is a previously uncharacterized yeast open reading frame that has been identified as a significant modulator of actin cable stability, mitochondrial function, and replicative lifespan in Saccharomyces cerevisiae. Research has demonstrated that deletion of YKL075C results in increased actin cable stability and abundance, improved mitochondrial fitness, and extended replicative lifespan .

Antibodies against YKL075C are valuable research tools because:

• They allow detection and localization of this low-abundance protein in cell biology studies

• They enable investigation of YKL075C's role in branched-chain amino acid (BCAA) metabolism

• They facilitate studies on cytoskeletal dynamics, as YKL075C interacts with ACT1 (the yeast actin gene)

• They support research on aging mechanisms, given the protein's impact on replicative lifespan

When designing antibodies against YKL075C, researchers should consider that the protein lacks obvious functional domains and has no known sequence similarity to other characterized proteins .

What experimental approaches are recommended for validating YKL075C antibody specificity?

Validating antibody specificity for YKL075C requires several complementary approaches:

Genetic validation:

• Compare antibody signal between wild-type and YKL075C deletion (ykl075c∆) strains

• Confirm loss of signal in knockout cells and restoration when the gene is reintroduced

Western blot verification:

• Detect a band of the expected molecular weight (~26 kDa)

• Include tagged versions (e.g., Myc-tagged YKL075C) as positive controls

Epitope mapping:

• Since YKL075C overlaps with another open reading frame (YKL076C), design epitopes that avoid cross-reactivity

• Verify that antibody recognizes recombinant YKL075C protein

Cross-reactivity assessment:

• Test against closely related proteins to ensure specificity

• Include appropriate blocking controls to minimize background

Remember that validation should account for YKL075C's naturally low abundance in yeast cells, as documented in previous studies .

What protein detection methods work best for YKL075C given its low abundance?

Because YKL075C protein (Ykl075cp) is not abundantly expressed in yeast cells , researchers should consider these optimized detection strategies:

Immunoblotting optimization:

• Use enhanced chemiluminescence (ECL) with high sensitivity substrates

• Increase protein loading (50-100 μg total protein)

• Extended exposure times may be necessary

• Consider concentration techniques like immunoprecipitation before detection

Immunofluorescence enhancements:

• Signal amplification systems (tyramide signal amplification)

• Confocal microscopy with sensitive photomultiplier tubes

• Consider epitope tagging strategies (multiple Myc tags as demonstrated in previous studies)

Protein enrichment approaches:

• Subcellular fractionation to concentrate the compartment where YKL075C localizes

• Affinity purification with optimized elution conditions

• Consider tag-based purification as researchers have successfully used 13 copies of the Myc epitope to detect YKL075C

Controls and standards:

• Include positive controls (e.g., overexpressed YKL075C)

• Use loading controls specific to the cellular compartment being analyzed

How should researchers interpret YKL075C antibody signals in the context of its genetic interaction with ACT1?

Interpreting YKL075C antibody signals requires understanding its relationship with ACT1 (the actin gene in yeast) and considering several factors:

Co-localization analysis:

• YKL075C has a genetic interaction with ACT1, suggesting functional relationships

• Evaluate whether YKL075C antibody signals co-localize with actin structures

• Quantify correlation coefficients between YKL075C and actin signals across different cellular regions

Functional context interpretation:

• ACT1 is involved in numerous cellular processes including DNA repair, actomyosin ring contraction, endocytosis, and cell polarity

• YKL075C deletion affects actin cable stability but not retrograde actin cable flow

• When interpreting co-localization, consider which ACT1 functions might be relevant

Genetic interaction scoring:

• The YKL075C-ACT1 interaction has a negative genetic interaction score (-0.1959)

• This negative score suggests that simultaneous disruption of both genes results in a more severe phenotype than expected

• Antibody signals should be interpreted with this synthetic interaction in mind

Quantitative considerations:

• Use appropriate controls when quantifying antibody signals

• Normalize signals using standard housekeeping proteins

• Consider the dynamic nature of actin structures when interpreting static images

What are the optimal fixation and permeabilization conditions for YKL075C antibody immunofluorescence in yeast cells?

For optimal detection of YKL075C by immunofluorescence, researchers should consider these specialized conditions:

Fixation protocols:

• Brief formaldehyde fixation (3-4% for 15-20 minutes) preserves cytoskeleton integrity

• Avoid methanol fixation as it can disrupt cytoskeletal structures

• For dual labeling with actin, use fixation conditions compatible with phalloidin staining

Permeabilization considerations:

• Gentle permeabilization with low concentrations of Triton X-100 (0.1-0.2%)

• For actin studies, digitonin (25 μg/ml) may provide more controlled permeabilization

• Enzymatic cell wall digestion with zymolyase may improve antibody access

Buffer composition:

• Use phosphate buffers with pH 6.5-7.0 to maintain yeast cell morphology

• Include protease inhibitors to prevent degradation of low-abundance targets

• Consider adding RNase to reduce background fluorescence

Cell cycle synchronization:

• Since actin structures change throughout the cell cycle, synchronize cells before fixation

• Use hydroxyurea or alpha-factor arrest methods depending on the cell cycle phase of interest

• Document the cell cycle stage when reporting YKL075C localization patterns

Image acquisition parameters:

• Use deconvolution to improve signal-to-noise ratio

• Z-stack imaging with appropriate step sizes (0.2-0.3 μm)

• Optimize exposure times to capture low-abundance signals without bleaching

How can YKL075C antibodies be used to investigate the protein's role in BCAA metabolism?

YKL075C has been implicated in branched-chain amino acid (BCAA) metabolism through transcriptome analysis . Researchers can use YKL075C antibodies to investigate this role through these specialized approaches:

Co-immunoprecipitation studies:

• Use YKL075C antibodies to pull down protein complexes

• Analyze for the presence of BCAA metabolism enzymes (particularly BAT1 and BAT2)

• Compare protein interactions under different BCAA availability conditions

Subcellular localization analysis:

• Determine if YKL075C localization changes in response to BCAA levels

• Dual staining with mitochondrial markers (where BAT1 localizes)

• Quantify co-localization coefficients under different nutritional states

Metabolic enzyme activity assays:

• Immunodeplete YKL075C and measure BAT1/BAT2 activity in vitro

• Compare enzyme kinetics with and without YKL075C

• Assess whether direct interaction or indirect regulation occurs

Proximity labeling approaches:

• Combine YKL075C antibodies with BioID or APEX2 proximity labeling

• Identify proteins in close proximity to YKL075C under different metabolic conditions

• Validate interactions with BCAA metabolic enzymes

Experimental design considerations:

• Include BCAA level measurements as demonstrated in previous studies

• Compare wild-type, ykl075c∆, bat1∆, and ykl075c∆bat1∆ strains

• Design experiments that can distinguish between transcriptional and post-transcriptional effects

What antibody-based techniques can researchers use to study YKL075C in relation to yeast aging and mitochondrial function?

Given YKL075C's influence on mitochondrial fitness and replicative lifespan , these specialized antibody-based approaches can provide valuable insights:

Chronological aging studies:

• Track YKL075C protein levels across different chronological ages

• Compare localization patterns between young and aged cells

• Correlate with mitochondrial morphology changes during aging

Replicative lifespan analysis:

• Use immunofluorescence to monitor YKL075C in mother cells across divisions

• Combine with age-related markers (e.g., Sir2) to correlate expression patterns

• Quantify relative abundance in young versus aged mother cells

Mitochondrial quality control assessment:

• Dual immunolabeling with mitochondrial markers

• Assess YKL075C localization during mitophagy

• Track protein levels during mitochondrial stress responses

Proteomic approaches:

• Immunoprecipitate YKL075C from young versus aged cells

• Compare interacting partners using mass spectrometry

• Identify age-dependent binding partners

Methodological details:

• When studying aged cells, use magnetic bead-based separation techniques to isolate old mother cells

• For mitochondrial studies, include functional assays (membrane potential, ROS production)

• Correlate antibody-based findings with known mitochondrial aging markers

What considerations are important when designing antibodies against different epitopes of YKL075C?

When designing antibodies targeting specific YKL075C epitopes, researchers should consider these specialized aspects:

Avoiding gene overlap regions:

• YKL075C overlaps with another open reading frame (YKL076C)

• Epitopes from the overlapping region may cause cross-reactivity

• Focus on unique N-terminal regions of YKL075C

Structural considerations:

• Despite lacking obvious functional domains , certain regions may be more exposed

• Predict surface-accessible regions using structural modeling tools

• Consider hydrophilicity plots to identify likely exposed regions

Functional region targeting:

• Design epitopes that may capture regions involved in BCAA regulation

• Consider regions potentially involved in actin interactions

• Develop multiple antibodies targeting different functional domains

Application-specific design:

• For immunoprecipitation: target stable, accessible epitopes

• For proximity labeling: ensure the antibody binding doesn't disrupt normal interactions

• For super-resolution microscopy: consider spatial constraints of the technique

Advanced epitope selection approaches:

• Phage display technology can help select optimal epitopes for antibody development

• Consider synthetic peptide arrays to identify immunogenic regions

• Validate epitope accessibility in native versus denatured states

How can researchers optimize co-immunoprecipitation protocols for studying YKL075C interactions with actin and other proteins?

For successful co-immunoprecipitation (co-IP) of YKL075C with its interaction partners, consider these specialized protocol optimizations:

Lysis buffer composition:

• Use gentle, non-ionic detergents (0.1-0.5% NP-40 or Triton X-100)

• Include cytoskeleton stabilization buffers for actin interaction studies

• Adjust salt concentration (100-150 mM NaCl) to maintain weak interactions

• Add protease and phosphatase inhibitors to preserve interaction states

Cross-linking considerations:

• For transient interactions, consider reversible cross-linkers (DSP, 0.5-2 mM)

• Optimize cross-linking time (5-30 minutes) to capture authentic interactions

• Include non-cross-linked controls to assess background

Antibody coupling strategies:

• Direct coupling to beads may reduce background (NHS-activated magnetic beads)

• For low-abundance targets, use larger volumes of cellular lysate

• Consider tag-based pulldown as an alternative, as previous studies used Myc-tagged YKL075C

Washing conditions:

• Optimize wash buffer stringency (detergent and salt concentration)

• Include graduated washes with decreasing stringency

• For actin interactions, consider specialized actin co-IP buffers with ATP

Elution and detection:

• Use mild elution conditions to preserve complex integrity

• For mass spectrometry analysis, consider on-bead digestion

• For Western blot verification, include size markers for both YKL075C and ACT1

Controls and validation:

• Use ykl075c∆ strains as negative controls

• Include input, unbound, and elution fractions in analysis

• Verify interactions with reciprocal co-IPs when possible

What are the advanced microscopy techniques that can be combined with YKL075C antibodies for studying actin dynamics?

Advanced microscopy approaches can overcome the challenges of detecting low-abundance YKL075C and studying its relationship with actin dynamics:

Super-resolution microscopy:

• STORM or PALM imaging for nanoscale localization

• Structured illumination microscopy (SIM) for improved resolution of actin structures

• Stimulated emission depletion (STED) microscopy for detailed cytoskeletal imaging

Live-cell imaging approaches:

• FRAP (Fluorescence Recovery After Photobleaching) to study YKL075C dynamics

• Single-molecule tracking with photoswitchable fluorophores

• Combine with fluorescently labeled actin to track co-dynamics

Correlative microscopy techniques:

• CLEM (Correlative Light and Electron Microscopy) to correlate antibody signals with ultrastructure

• Expansion microscopy to physically enlarge samples for improved resolution

• Array tomography for 3D reconstruction of YKL075C localization

Proximity detection methods:

• FRET (Förster Resonance Energy Transfer) to study molecular interactions

• BiFC (Bimolecular Fluorescence Complementation) for direct interaction visualization

• Proximity ligation assay (PLA) to detect proteins within 40 nm of each other

Optimization considerations:

• For dual-color imaging, correct for chromatic aberration

• Use quantum dots or other photostable fluorophores for extended imaging

• Consider microfluidic systems for controlled perturbation experiments

Quantitative analysis approaches:

• Particle tracking for dynamic analysis

• Colocalization analysis with appropriate statistical metrics

• Machine learning-based segmentation and classification

How can YKL075C antibodies be used in combination with actin-modulating drugs to investigate cytoskeletal regulation?

YKL075C deletion strains show reduced sensitivity to Latrunculin A (Lat-A), suggesting a role in actin stability . Researchers can exploit this relationship using these approaches:

Drug sensitivity assays:

• Compare YKL075C localization before and after Lat-A treatment

• Track protein levels during actin depolymerization and recovery

• Determine if YKL075C phosphorylation state changes with actin perturbation

Mechanistic investigations:

• Use YKL075C antibodies to assess protein interactions under different drug treatments

• Compare wild-type versus mutant responses to cytoskeletal perturbations

• Investigate whether YKL075C directly or indirectly affects actin stability

Combined perturbation approaches:

• Manipulate BCAA levels while treating with actin-modulating drugs

• Assess YKL075C localization during combined treatments

• Determine if YKL075C acts as a sensor connecting BCAA metabolism to cytoskeletal dynamics

Experimental design details:

• For Lat-A experiments, use low concentrations as in previous studies (50-200 nM)

• Include time-course studies to track dynamic responses

• Compare effects of different actin-modulating drugs (Latrunculin A, Cytochalasin D, Jasplakinolide)

Controls and validation:

• Include both wild-type and ykl075c∆ strains in all experiments

• Verify actin structure changes using standard markers

• Consider complementation experiments with plasmid-expressed YKL075C

What methodological approaches can distinguish between direct and indirect effects of YKL075C on actin cable stability?

Determining whether YKL075C directly or indirectly affects actin cable stability requires sophisticated experimental designs:

In vitro reconstitution assays:

• Purify YKL075C (or domains) using antibody-based affinity columns

• Test direct effects on actin polymerization in cell-free systems

• Measure effects on actin filament nucleation, elongation, and depolymerization rates

Domain-specific antibodies:

• Generate antibodies against different YKL075C domains

• Use domain-specific antibodies to block potential interaction surfaces

• Determine which domains are essential for actin-related functions

Proximity analysis methods:

• BioID or APEX2 proximity labeling to identify proteins near YKL075C

• Chemical cross-linking followed by mass spectrometry (XL-MS)

• Fluorescence correlation spectroscopy to detect direct binding

Genetic interaction mapping:

• Expand on the known YKL075C-ACT1 negative genetic interaction

• Create a comprehensive genetic interaction network around YKL075C

• Use antibodies to validate protein-level consequences of genetic interactions

Metabolic coupling tests:

• Since YKL075C affects BCAA metabolism , test if BCAAs directly modulate actin

• Use antibodies to track YKL075C localization under different metabolic conditions

• Determine if leucine restriction mimics YKL075C deletion effects on actin